AI Analysis AI Analysis of AQST AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add AQST to Watchlist?
Some Reasons Why To Add AQST:
  • Strong return on equity of 190.9%
  • High gross margin of 63.5%
  • Highly efficient cash conversion (101% FCF/OCF ratio)
PDF

Aquestive Therapeutics Inc. stock price down 0.672% on Friday
(Updated on Jul 31, 2026)

Sell candidate since Jul 23, 2026 Loss -1.99%

The Aquestive Therapeutics Inc. stock price fell by -0.672% on the last day (Friday, 31st Jul 2026) from $3.72 to $3.70. During the last trading day the stock fluctuated 4.16% from a day low at $3.61 to a day high of $3.76. The price has fallen in 6 of the last 10 days and is down by -10.32% for this period. Volume has increased on the last day by 353 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $6.56 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.59 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -6.05% during the next 3 months and, with a 90% probability hold a price between $3.37 and $4.60 at the end of this 3-month period.

AQST Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 2.64%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aquestive Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.71 and $4.16. A break-up above any of these levels will issue buy signals. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Aquestive Therapeutics Inc. stock

Aquestive Therapeutics Inc. finds support from accumulated volume at $3.68 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.150 between high and low, or 4.16%. For the last week, the stock has had daily average volatility of 5.09%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AQST) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Aquestive Therapeutics Inc. to open at $3.69, and during the day (based on 14 day Average True Range), to move between $3.60 and $3.79, which gives a possible trading interval of +/-$0.197 (+/-5.49%) up or down from last closing price. If Aquestive Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 5.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.68 (0.41%) than the resistance at $4.12 (11.50%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Aquestive Therapeutics Inc. will release earnings AMC on Monday, August 10, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.100. We will update the financials statements for Aquestive Therapeutics Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 7.19% in the first trading day after earnings release.

Is Aquestive Therapeutics Inc. stock A Buy?

Aquestive Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.330 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $3.69 ( 0.271%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

AQST Performance

Trading levels for AQST

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.84 3.79%
R2 3.78 2.24%
R1 3.74 1.28%
Price 3.70
S1 3.63 -1.82%
S2 3.59 -2.78%
S3 3.54 -4.33%

Accumulated Volume Support & Resistance Levels

Level Price
R3 4.39 18.81%
R2 4.16 12.58%
R1 4.12 11.50%
Price 3.70
S1 3.68 -0.406%
S2 3.60 -2.57%
S3 0 -

FAQ

What is the symbol for Aquestive Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Aquestive Therapeutics Inc. is AQST and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aquestive Therapeutics Inc. Stock?
Aquestive Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Aquestive Therapeutics Inc. Stock?
Aquestive Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aquestive Therapeutics Inc. Stock.

What's the current price of Aquestive Therapeutics Inc. Stock?
As of the end of day on the Jul 31, 2026, the price of an Aquestive Therapeutics Inc. (AQST) share was $3.70.

What is the 52-week high and low for Aquestive Therapeutics Inc. Stock?
The 52-week high for Aquestive Therapeutics Inc. Stock is $7.55 and the 52-week low is $2.94.

What is the market capitalization of Aquestive Therapeutics Inc. Stock?
As of the Jul 31, 2026, the market capitalization of Aquestive Therapeutics Inc. is 463.601M.

When is the next earnings date for Aquestive Therapeutics Inc.?
The upcoming earnings date for Aquestive Therapeutics Inc. is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT AQUESTIVE THERAPEUTICS INC.
Aquestive Therapeutics
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral ...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE